Tachykinins and tachykinin receptors: a growing family

被引:379
作者
Pennefather, JN
Lecci, A
Candenas, ML
Patak, E
Pinto, FM
Maggi, CA
机构
[1] Ctr Invest Cientificas Isla La Cartuja, Inst Invest Quim, Seville 41092, Spain
[2] Monash Univ, Victorian Coll Pharm, Dept Pharmaceut Biol & Pharmacol, Parkville, Vic 3052, Australia
[3] Menarini Ric SpA Res Labs, Dept Pharmacol, I-50131 Florence, Italy
[4] Royal Hosp Women, Dept Anaesthet, Carlton, Vic 3053, Australia
关键词
tachykinins; tachykinin receptors; substance P; neurokinin A; neurokinin B; endokinins A; B; C; D;
D O I
10.1016/j.lfs.2003.09.039
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The peptides of the tachykinin family are widely distributed within the mammalian peripheral and central nervous systems and play a well-recognized role as excitatory neurotransmitters. Currently, the concept that tachykinins act exclusively as neuropeptides is being challenged, since the best known members of the family, substance P, neurokinin A and neurokinin B, are also present in non-neuronal cells and in non-innervated tissues. Moreover, the recently cloned mammalian tachykinins hemokinin-1 and endokinins are primarily expressed in non-neuronal cells, suggesting a widespread distribution and important role for these peptides as intercellular signaling molecules. The biological actions of tachykinins are mediated through three types of receptors denoted NK1, NK2 and NK3 that belong to the family of G protein-coupled receptors. The identification of additional tachykinins. has reopened the debate of whether more tachykinin receptors exist. In this review, we summarize the current knowledge of tachykinins and their receptors. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1445 / 1463
页数:19
相关论文
共 135 条
[61]   Human lymphocytes express substance P and its receptor [J].
Lai, JP ;
Douglas, SD ;
Ho, WZ .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 86 (01) :80-86
[62]   Initial sequencing and analysis of the human genome [J].
Lander, ES ;
Int Human Genome Sequencing Consortium ;
Linton, LM ;
Birren, B ;
Nusbaum, C ;
Zody, MC ;
Baldwin, J ;
Devon, K ;
Dewar, K ;
Doyle, M ;
FitzHugh, W ;
Funke, R ;
Gage, D ;
Harris, K ;
Heaford, A ;
Howland, J ;
Kann, L ;
Lehoczky, J ;
LeVine, R ;
McEwan, P ;
McKernan, K ;
Meldrim, J ;
Mesirov, JP ;
Miranda, C ;
Morris, W ;
Naylor, J ;
Raymond, C ;
Rosetti, M ;
Santos, R ;
Sheridan, A ;
Sougnez, C ;
Stange-Thomann, N ;
Stojanovic, N ;
Subramanian, A ;
Wyman, D ;
Rogers, J ;
Sulston, J ;
Ainscough, R ;
Beck, S ;
Bentley, D ;
Burton, J ;
Clee, C ;
Carter, N ;
Coulson, A ;
Deadman, R ;
Deloukas, P ;
Dunham, A ;
Dunham, I ;
Durbin, R ;
French, L .
NATURE, 2001, 409 (6822) :860-921
[63]   Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses [J].
Lecat, S ;
Bucher, B ;
Mely, Y ;
Galzi, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) :42034-42048
[64]   Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases [J].
Lecci, A ;
Maggi, CA .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (03) :343-362
[65]   Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system [J].
Lecci, A ;
Maggi, CA .
REGULATORY PEPTIDES, 2001, 101 (1-3) :1-18
[66]  
LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282
[67]   IDENTIFICATION OF IMMUNOREACTIVE SUBSTANCE-P IN HUMAN AND OTHER MAMMALIAN ENDOTHELIAL-CELLS [J].
LINNIK, MD ;
MOSKOWITZ, MA .
PEPTIDES, 1989, 10 (05) :957-962
[68]   Bufokinin: immunoreactivity, receptor localization and actions in toad intestine and mesenteric circulation [J].
Liu, L ;
Shang, F ;
Perry, MA ;
Comis, A ;
Burcher, E .
PEPTIDES, 2000, 21 (09) :1345-1354
[69]   Neurochemical classification of enteric neurons in the guinea-pig distal colon [J].
Lomax, AE ;
Furness, JB .
CELL AND TISSUE RESEARCH, 2000, 302 (01) :59-72
[70]  
Lundberg JM, 1996, PHARMACOL REV, V48, P113